Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :4625
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome TM ) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India

Jadhav M P, Shinde V M, Chandrakala S, Jijina F, Menon H, Arora B, Kurkure P A, Parikh P M, Kshirsagar N A

Year : 2012| Volume: 49| Issue : 1 | Page no: 107-113

   This article has been cited by
1 Sixty years of Amphotericin B: An Overview of the Main Antifungal Agent Used to Treat Invasive Fungal Infections
Francelise B. Cavassin, Joăo Luiz Baú-Carneiro, Rogério R. Vilas-Boas, Flávio Queiroz-Telles
Infectious Diseases and Therapy. 2021; 10(1): 115
[Pubmed]  [Google Scholar] [DOI]
2 Nanoparticles as safe and effective delivery systems of antifungal agents: Achievements and challenges
Ghareb M. Soliman
International Journal of Pharmaceutics. 2017; 523(1): 15
[Pubmed]  [Google Scholar] [DOI]
3 Efficacy and safety of amphotericin B formulations: a network meta-analysis and a multicriteria decision analysis
Fernanda S. Tonin,Laiza M. Steimbach,Helena H. Borba,Andreia C. Sanches,Astrid Wiens,Roberto Pontarolo,Fernando Fernandez-Llimos
Journal of Pharmacy and Pharmacology. 2017; 69(12): 1672
[Pubmed]  [Google Scholar] [DOI]
4 Efficacy and safety of amphotericin B lipid-based formulations-A systematic review and meta-analysis
Laiza M. Steimbach,Fernanda S. Tonin,Suzane Virtuoso,Helena H. L. Borba,Andréia C. C. Sanches,Astrid Wiens,Fernando Fernandez-Llimós,Roberto Pontarolo
Mycoses. 2017; 60(3): 146
[Pubmed]  [Google Scholar] [DOI]
5 Empiric treatment against invasive fungal diseases in febrile neutropenic patients: a systematic review and network meta-analysis
Ken Chen,Qi Wang,Roy A. Pleasants,Long Ge,Wei Liu,Kangning Peng,Suodi Zhai
BMC Infectious Diseases. 2017; 17(1)
[Pubmed]  [Google Scholar] [DOI]
6 Comparison between liposomal formulations of amphotericin B
Jill P Adler-Moore,Jean-Pierre Gangneux,Peter G Pappas
Medical Mycology. 2016; 54(3): 223
[Pubmed]  [Google Scholar] [DOI]
7 Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function
Juan Pablo Botero Aguirre,Alejandra Maria Restrepo Hamid
Cochrane Database of Systematic Reviews. 2015;
[Pubmed]  [Google Scholar] [DOI]
8 Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia
Helle Krogh Johansen,Peter C Gřtzsche
Cochrane Database of Systematic Reviews. 2014;
[Pubmed]  [Google Scholar] [DOI]
9 Liposomal antibiotics for the treatment of infectious diseases
Moayad Alhariri,Ali Azghani,Abdelwahab Omri
Expert Opinion on Drug Delivery. 2013; 10(11): 1515
[Pubmed]  [Google Scholar] [DOI]


  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow